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ABSTRACT 
Basti Chikitsakarma is one of supreme therapy for the elimination of vitiated Vatadosha and has entity to 
entice all Doshas. In the present clinical practice with the reference of Acharya Sushruta, the scientific 
application of Utkleshana, Doshaharaand Samshana Vasti has an approach towards Datugatadoshaharana 
in all aspects of diseases. Among them one of the most crippling, disabling and debilitating disorder is 
Amavata. So looking to the etiopathogenesis of Amavata, it shows a Bahudoshayuktavyadhi mainly 
involvement Vata, Kaphadosha’s and a part of Pitta predominantly. Its Udbhavasthana in Ama Pakwashaya, 
Sancharasthana in Rasavaha and Annavahasrotas, Adhistana and Vyktasthana are Kaphasthana like 
Amashaya Sandhi etc. As it is a Kastasadhyaswabhava, it needs a complete inclusive treatment. In that view 
the application of Utkleshanabasti, followed by Doshaharabasti and finally Samshamanabasti is selected.  
A total of 30 patients presenting with symptomatology of Amavata were simple randomly selected for 
study. The study design, schedule, duration and follow-up of the treatment have clearly explained. 
Subjective and objective criteria’s were statistically analyzed before and after treatment by applied 
standard statistical method. All subjective and objective parameters showed highly substantial significant 
result of 73.33% and 80.28 mean grade result found among 22 patients out of 30 Amavata patients and a 
high significant fair result of 26.66% and 71.96 mean grade result found among 08 patients out of 30 
Amavata patients. The overall assessment mean result was 76.12 in both subjective and objective 
parameters were observed. 
KEYWORDS: Utkleshana, Doshahara, Samshamana, Rasayana, Dhatugata Dosha, Amavata. 
INTRODUCTION 
 Modern medicine has established its mastery in 
every branch of specialization. For Ayurveda, Panchakarma 
is its unique contribution in all perspectives. The 
importance of Panchakarma in Ayurveda is borne out by 
the fact that it is applicable to all cases covering a wide 
range of preventive, curative and promotive conditions. It 
is postulated that the vitiated Doshas and Malas of the 
body need to be eliminated before any specific measure is 
taken to cure the disease because no one therapy works 
well if Shodhana measures are not taken beforehand.  
Aama is the basic concept of Ayurveda in several 
diseases. Diseases occurs by Aama is a type of 
constitutional diseases. 80% of the disorders in the world 
are of Samarogas. Out of them most crippling and 
debilitating disorder, which hampers the economy of the 
world as well as the individual, are musculoskeletal 
disorders. These are best known as rheumatic disorders. 
As per ACR (American college of Rheumatology) 
classification and international classification of 
rheumatological disorders all appear to be Samarogas. Out 
of such disorders, many disorders have got signs and 
symptoms similar to Amavata. The disease was first 
explained in detail manner by Acharya Madhavakara in 
Madhavanidhana during the period of 7th century AD.1 He 
covers a verity of Rheumatological disorders under the 
light of Amavata. 
It is a disorder characterized by Amadosha, 
Vatadosha, Kaphadosha (Bahudoshayukta) morbidly. This 
is a disease where in Rasavahasrotas is primarily involved. 
Because of this, the pain spreads from one joint to another 
joint very quickly. Rasavahasrotomoola is Hridaya and 
“Rasathiaharahargachathi” Guna of Rasadhatu lead to the 
involvement of whole body in short span of time. Being a 
disease of Madhyamarogamarga, involvement of Marma 
(Hridaya) makes this disease more and more critical.2 The 
treatment proper is also not unidirectional, for e.g.: the 
antagonistic treatment of Kaphadosha, Amadosha and 
Vatadosha must be carried out simultaneously and 
involvement of Gambiradhatu (Asthi) and Uttanadhatu 
(Rasa), makes the treatment still more puzzle.  
So looking to the etiopathogenesis of Amavata, 
Sampraptivighatana chikitsa (Vatadosha, Kapha Dosha, 
Part of Pitta Dosha, Agnidusti and Ama in both Uttana-
dhtugataavastha as well as Gambhiradhaatugataavastha) 
demands Shodanachikitsa to eliminate the Anuban-
ditadosha along with Vatadosha. 
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Acharyas told different type of Shodhana in our 
classics among them the best one and half of the treatment 
or full of the treatment credit goes to the Bastichikitsa 
because of Basti is one such Shodhana procedure having 
multifaceted approach. Simultaneously Basti is also 
considered as the treatment of excellence in controlling 
the painful conditions.  
So in case of Amavata it is necessary to bring back 
the Dosha’s from Shakha to Kosta, because of its 
complicated Samprapti and nature of wide spreading. For 
bringing the Dosha from Shakha to Kosta. Acharya Sushruta 
has made a set of Packaged Basti known as Utkleshana, 
Doshahara and Samashamana in a sequential manner.3 No 
doubt by Snehana, Swedana the tremendous Utlkleshana of 
Doshas and to bring back them to Kosta is achieved but as 
comparing to Utkleshana Basti the prior one has more time 
consuming, non-palatable and in case of emergency it’s not 
so easy, in case of Basti it over comes all the problems of 
Snehana and Swedana. The similar concept also holds good 
in the Doshahara and Samshamana Basti.  
For Amavata different variety of treatment 
concepts are explained in Ayurveda, in view of its acute 
level to chronic level. Among them Basti is one of the major 
treatment. Keeping the above in view the study of 
Utklehana Basti, Doshahara Basti and Samshamana Basti in 
Amavata in the frame of Kala Basti was taken up, as 
mentioned by Acharya Sushruta.4 
The Utkleshaka drugs like Erandabeeja, Madhuka, 
Pippalietc, Doshahara drugs like Shatahwa, Madhuka, 
Madhanaphala, Gomutra, Kanjietc and Samshamana drugs 
like Priyangu, Musta, Rasanjana, Goksheera etc5 are 
schematically arranged in the pattern of Kala Basti, i.e. 
within total six Niruha Basti, the first two Basti are 
Utkleshana, the middle two are Doshahara and last two 
become Samshamana. The remaining ten are Anuvasana 
Basti’s with Bruhatsaindhavadhya taila.6 
The observations on the effect of these procedures 
will be studied in a specific manner and the results will be 
enlightened and it will be presented in scientific analytical 
way. 
Aims and Objectives of the Study 
1) To assess the impact and consequences of Utkleshsana 
Basti, Doshahara Basti and Samshamaniya Basti in 
Amavaata. 
2) An analytical study over Doshotkleshata, 
Doshaharatwa and Doshashamanatwa by Basti 
Procedure. 
Clinical Study Protocol 
A clinical study was carried out in following ways: 
Source of Data 
1. The present study is a clinical trial. Hence the 
patients will be selected from N.K.J Ayurvedic 
medical college and hospital.  
2. Ayurveda classics and Modern texts. 
3. National and international Seminar, journals/ 
magazines. 
Methods of Collection of Data 
1. Patients will be selected by simple randomised 
sampling procedure. 
2. Separate Charts (proforma) will be prepared, 
recording the signs and symptoms of Aamavata and 
Laxanas of Utkleshana, Doshahara and Samshamana 
of Dosha, due to the impacts of Basti karma 
procedure respectively.  
3. Procedure will be conducted under the supervision of 
guide and co guide. 
Research design 
 30 Patients will be selected by simple randomized 
method for the study within a single group. 
 It is a single blind clinical study with pre-test and 
post-test design. 
 Utkleshana, Doshahara and Samshamana Basti as 
explained by Acharya Sushrutachikitsa 38/92 will be 
administered to all patients. 
 Pre procedures i.e. Poorvakarma should be 
compulsory and mandatory.  
  Before starting treatment thorough counseling of 
patient and brief explanation regarding the 
procedure of Basti karma will be done  
 All Patients should be advised to follow the specific 
diet chart during the therapy and till Pariharakaala 
completes. 
Selection of Chikitsa7 
 Bastichikitsa selected 
Selection of Basti8 
 Utkleshana Basti 
 Doshahara Basti 
 Samshamana Basti in sequence 
Schedule of Basti 
 Utkleshana, Doshahara and Samshamana Basti in 
sequence will be administered in the frame work of Kaala 
Basti as shown below. 
Table 1: Showing Schedule of Utkleshana, Doshahara and Samshamana Basti 
No of Vasti 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Type of Vasti A U A U A DH A DH A SS A SS A A A A 
Note: Here UB= UtkleshanaBasti, DHB = DoshaharaBasti, SSB = SamshamanaBasti 
Duration of Basti 
 16 days followed by Parihaarakala 
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Table 2: Showing Intervention chart 
Sl. No Procedure Drug Dose Duration 
1 Poorva karma 
Sarvangaabhyanga 
Bhaspasweda 
 
Moorchitatilataila 
Dashamooladravya’s 
 
Q.S 
 
30 to 40 mins. 
10 – 15mins.  
2 Pradhana karma 
(Kaalavasti) 
Anuvasanavasti 
 
Niroohavasti 
a) Utkleshanabasti 
Dravya’s 
Erandabija, Madhuka, Pippali, 
Saindavalavana, Vacha, and 
Haphushakalka 
 
 
Bruhatsaindavadhyataila 
 
Saindavalavana 
Madhu 
Moorchitatilataila 
Utkeshanabastigatadravyakalka 
Utkeshanabastigataquatha 
 
 
120 ml 
 
10gm 
40-60gm 
100120ml 
50-60gm 
500-550ml 
 
 
1st,3rd,5th,7th,9th,11th, 
13th,14th,15th,16th 
 
 
2nd, 4th day 
Total Approximate  800 ml  
 b)Doshaharabasti Dravya’s 
Shatahwa, madhuKa, kutaja 
Beeja, Madanaphala, Kaanjika 
and Gomootra 
Saindavalavana 
Madhu 
Moorchitatilataila 
Dishaharabastigatadravyakalka 
Doshaharabastigatakashaya 
10gm 
40-60gm 
100120ml 
50-60gm 
500 -550ml  
 
 
 
6th and 8th day  
Total Approximate  800 ml  
 c)Samshamanabastidravya’s 
Priyangu, Madhuka, Musta, 
RasanjanaandKsheera 
 
Saindavalavana 
Madhu 
Moorchitatilataila 
Samshamanabastigatadravyakalka 
Samshamanabastigatakashaya 
10gm 
40-60gm 
100-120ml 
50-60gm 
500-550ml 
 
 
10th and 11th day 
 
Total Approximate  800 ml  
 Paschath karma Lift the legs, padding to the buttocks, 
anti-clockwise massage to abdomen 
etc.  
 8-10 mins. 
Follow up 
There will be two follow ups conducted i.e. 1st soon after the treatment (on 16th Day) and 2nd will be 32nd day after 
the treatment. 
Selection Criteria 
a) Inclusion Criteria 
1. Patients presenting with the clinical signs and symptoms of Aamavata will be selected. 
2. Patients age between 18-60 years irrespective of sex and socio economic state. 
3. Patients fit for Bastichikitsa. 
b) Exclusion Criteria 
1. Amavata associated with Upadrava and Arista laxana. 
2. Amavata associated with cardiac diseases other severe complicated diseases. 
3. Amavata condition followed by or associated with involvement of Pitta, Rakta, Paaka and acute Dhatukshaya. 
4. Patients with severe deformities, severe ankylosed joints, septic arthritis and gouty arthritis etc 
5. Patients with genetic and hereditary disorders.   
6. Pregnant women. 
7. Patients not fit for Bastichikitsa. 
Assessment criteria 
Subjective and objective parameters will be assessed based before and after treatment with appropriate statistical 
analysis. 
Parameters for Assessment 
Table 3: Showing List of Subjective parameters9 
1) ApakashoonataAnga 6) SandhiGraha (Restricted movements of joints ) 
2) Bhramanasheelatwa 7) Jwara 
3) Vruschikadamshavatvedana 8) Vivarnata (Localized discoloration ) 
4) BahuSandhiShoola ( Multiple joint Pain ) 9) Bahumotratwa 
5) BahuSandhiShotha (Multiple joint inflammation ) 10) Stambha ( Stiffness ) 
Mahantagouda Biradar et al. Effect of Utkleshana, Doshahara and Samshamana Vasti in the Management of Amavata 
 Available online at: http://ijapr.in  8 
The above Parameters include standard ACR diagnostic criteria, due to the fear of expansion here not elaborated. 
Objective Parameters 
1. Hb%  
2. ESR 
3. CRP 
4. ASO titre 
5. RA Test 
Clinical Assessment Scoring Method 
 The changes observed in the signs and symptoms were assessed by adopting suitable scoring method and the 
objective signs by using appropriate clinical tools. The details of scoring pattern adopted for assessment of clinical signs 
and symptoms is as follows: 
Subjective Parameters Assessment Scoring Method 
Table 4: Apakashoonataangha (swelling with no inflammatory changes) 
No Swelling  Grade 0 
Joint swelling which may not be apparent on casual inspection, but 
difficult to recognize on casual observation  
Grade 1 
Joint swelling obvious even on casual observation Grade 2 
Markedly abnormal swelling Grade 3 
Joint swelling to a maximally abnormal degree Grade 4 
Table 5: Bhramanasheelatwa 
No Bhramanasheelatwa Grade 0 
Mild BhramanaSheelatwa Grade 1 
Minimal BhramanaSheelatwa Grade 2 
Moderate BhramanaSheelatwa Grade 3 
Severe BhramanaSheelatwa Grade 4 
Table 6: Vruschikadamshavatvedana 
No tenderness Grade 0 
Slight or mild tolerable discomfort on palpation Grade 1 
More severe pain on ordinary palpation Grade 2 
More intolerable pain even with light palpation or pressure Grade 3 
Pain which may be caused by even a mild stimulus Grade 4 
Table 7: Bahusandhishula (multiple joint pain (as per Harrison’s grading method)10 
Pain in 1 large joint. Grade 0 
Pain in 2-10 large joints with mild nature  Grade 1 
Pain in 1-3 small joints (with or without involvement of large joints) Grade 2 
Pain in 4-10 small joints (with or without involvement of large joints Grade 3 
Pain in more than 10 joints (with involvement of at least 1 small joint Grade 4 
Table 8: Bahusandhishotha (multiple joint inflammation as per Harrison’s grading method)11 
Involvement of 1 - 2 large joint with minimal nature Grade 0 
Involvement of 3-10 large joints with mild nature  Grade 1 
Involvement of 1-3 small joints (with or without involvement of large joints) with moderate nature Grade 2 
Involvement of 4-10 small joints (with or without involvement of large joints with marked nature Grade 3 
Involvement of more than 10 joints (with involvement of at least 1 small joint with severe nature  Grade 4 
Table 9: Sandhi Graha (Restricted movements of joints) 
Normal joint motion Grade 0 
About 25 - 49% loss of motion Grade 1 
About 50% loss of motion Grade 2 
About 75% loss of motion Grade 3 
100% loss of motion or complete ankyloses of the joint Grade 4 
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Table 10: Jwara In Fahrenheit 
No fever Grade 0 
Low Grade fever (100.4–102.2) Grade 1 
Moderate Grade fever (102.2–104.0) Grade 2 
High grade fever (104.0–106.0) Grade 3 
Hyper pyrexia (>106.0) Grade 4 
Table 11: Vivarnata (Localized discoloration) 
Absent Grade 0 
Mild  Grade 1 
Moderate Grade 2 
Marked Grade 3 
Severe  Grade 4 
Table 12: Bahumotratwa 
Normal( 4 – 5 times/24 hrs) Grade 0 
Mild (6 – 7 times/24 hrs) Grade 1 
Moderate (8 – 9 times/24 hrs) Grade 2 
Severe (10 – 11 times/24hrs ) Grade 3 
Very severe(More than 12 times) Grade 4 
Table 13: Sandhi Stambha (Morning Stiffness) 
No stiffness or stiffness lasting for 5 minutes  Grade 0 
Stiffness lasting for 6 minutes to 30 minutes  Grade 1 
Stiffness lasting for 35 minutes to 1 hour  Grade 2 
Stiffness lasting for 1 ½ hour to 2 hour  Grade 3 
Stiffness lasting for more than 2 hour  Grade 4 
Objective parameters assessment scoring method 
Table 14: Hb% Assessment Grading 
Normal (12 to 15.8 mg/dl) Grade 0 
Mild (10.4 to 11.9 mg/dl) Grade 1 
Moderate (8.8 to 10.3 mg/dl) Grade 2 
Marked (7.2 to 8.7 mg/dl) Grade 3 
Severe (6.6 to 7.1mg/dl )  Grade 4 
Table 15: ESR Assessment Grading 
0to20mm Grade 0 
21to40 Grade 1 
41to60 Grade 2 
61 to 80 Grade 3 
Above 80  Grade 4 
Table 16: CRP Assessment Grading 
Negative (˂ 10 mg/dl) Grade 0 
Low (10.1 to 10.9 mg/dl) Grade 1 
Average (11 to 11.9 mg/dl) Grade 2 
Moderate (12 to 12.9 mg/dl) Grade 3 
High (More than 12.9 mg/dl) Grade 4 
Table 17: ASO Assessment Grading 
Normal (< 200 IU/ml) Grade 0 
Low (200 – 300 IU/ml) Grade 1 
Average (301 – 400 IU/ml) Grade 2 
Moderate (401 – 500 IU/ml) Grade 3 
High (More than 501IU/ml) Grade 4 
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Table 18: RF Assessment Grading 
Negative RF(25 – 50 IU/ml) Grade 0 
Low positive(51 – 55 IU/ml) Grade 1 
Moderate positive(56 – 60 IU/ml) Grade 2 
Marked positive(61 – 65 IU/ml) Grade 3 
High positive (More than 65 IU/ml) Grade 4 
RESULTS 
Effect on Subjective Parameters (Cardinal Signs & Symptoms) 
Table 19: Showing, Effect of therapy on Apaka Shoonata Anga 
Total no of 
 Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 2.66 AT1 1.76 0.9 33.75 0.62 0.11 16.15 P<0.01 
AT2 0.63 2.03 76.25 0.49 0.08 18.11 P<0.01 
Table 20: showing, Effect of therapy on Bramana Sheelatwa 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.2 AT1 2.1 1.1 34.37 0.60 0.11 14.96 P<0.01 
AT2 0.8 2.4 75 0.55 0.10 23.33 P<0.01 
Table 21: showing, Effect of therapy on Vruschika Damshavat Vedana 
Total no of 
 Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 2.96 AT1 1.93 1.03 34.8 0.52 0.09 13.67 P<0.01 
AT2 0.73 2.23 75.28 0.44 0.08 19.53 P<0.01 
Table 22: showing, Effect of therapy on Bahu Sandhishoola 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.5333 AT1 2.13 1.4 39.62 0.62 0.11 15.38 P<0.01 
AT2 0.76 2.76 78.30 0.50 0.09 30.06 P<0.01 
Table 23: Showing, Effect of therapy on Bahu Sandhishotha 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.533 
 
AT1 2.2 1.33 37.73 0.66 0.12 13.35 P<0.01 
AT2 0.9 2.63 74.52 0.66 0.12 20.07 P<0.01 
Table 24: Showing, Effect of therapy on Sandhi Graha 
Total no of  
Patients 
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.1666 
 
AT1 2.5 0.66 21.05 0.73 0.13 7.61 P<0.01 
AT2 0.76 2.4 75.78 0.67 0.12 23.33 P<0.01 
Table 25: Showing, Effect of therapy on Jwara 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 2.7666 
 
AT1 2.33 0.43 15.66 0.71 0.12 4.70 P<0.01 
AT2 0.7 2.06 74.69 0.70 0.12 21.73 P<0.01 
Table 26: Showing, Effect of therapy on Vivarnata 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.4 AT1 2.73 0.66 19.60 0.73 0.13 6.67 P<0.01 
AT2 0.8 2.6 76.47 0.66 0.12 28.58 P<0.01 
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Table 27: Showing, Effect of therapy on Bahu Mootratwa 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.3333 AT1 2.6 0.7 22 0.62 0.11 8.93 P<0.01 
AT2 0.66 2.66 80 0.60 0.11 30.46 P<0.01 
Table 28: Showing, Effect of therapy on Stamba 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.5 AT1 2.6 0.9 25.71 0.67 0.12 9 P<0.01 
AT2 0.8 2.7 77.14 0.61 0.11 27.64 P<0.01 
Effect of Therapy on Objective Parameters 
Table 29: Showing, Effect of therapy on Hb% 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 2.6 
 
AT1 0.53 2.06 79.48 0.50 0.09 21.73 P<0.01 
AT2 0.36 2.23 85.89 0.49 0.08 21.52 P<0.01 
Table 30: Showing, Effect of therapy on ESR % 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.4 AT1 1.5 1.9 55.88 0.50 0.092 19 P<0.01 
AT2 0.53 2.86 84.31 0.50 0.092 24.96 P<0.01 
Table 31: Showing, Effect of therapy on RA % 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.5 AT1 2.26 1.2 35.23 0.73 0.13 15.70 P<0.01 
AT2 1.6 1.9 54.28 0.67 0.12 21.65 P<0.01 
Table 32: Showing, Effect of therapy on ASO % 
Total no of  
Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.1666 AT1 0.7 2.46 77.89 1.05 0.19 15.01 P<0.01 
AT2 0.4 2.76 87.36 0.67 0.12 26.66 P<0.01 
Table 33: Showing, Effect of therapy on CRP % 
Total no of 
 Patients  
BT AT Mean d % Paired ‘t’ test Result 
S.D.± S.E.± t P H.S 
30 3.7333 AT1 0.63 3.1 83.03 1.03 0.18 15.52 P<0.01 
AT2 0.3 3.43 91.96 0.59 0.10 25.83 P<0.01 
Table 34: Showing, Overall effect of Therapy 
Treatment Response  Total effect of 
treatment in % 
Total No. of Patients  Percentage  Mean grade result 
No response to Therapy  0%  00 00 00 
Mild response to therapy  1 – 25%  00 00 00 
Moderate response to therapy  25.1% - 50%  00 00 00 
Fair response to therapy  50.1% - 75%  8 26.66 71.96 
Good response to therapy  75.1% - 100%  22 73.33 80.28 
DISCUSSION
Brief mode of action of Utkleshana, Doshahara and 
Samshanabasti 
 The Utkleshana Basti having the properties of 
Teekshana, Snigdha, Laghu, Sookshma, Picchila and Part of 
Guru, are having similar properties of Kapha and Ama by 
that they spread to all over the body with the help of 
Apana Samana and Vyanavayu through the medium of 
Rasavahasrotas, their increase in the quantitative 
consistency of Doshothklesha, and bring back to the Kosta 
i.e. Pakwashaya and expel the unwanted mala by keeping 
Uthklistadosha in their own site, followed by 
administration of Doshaharabasti causes the elimination of 
Dhatugatadosha and Utklistadosha from its root level by 
the virtue of its Ushana, Teekshna, Vyavayi, Vikashi and 
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Srotogamiguna’s, after that, at lastly for the purpose of 
Pacification of Leenadosha, to prevent the further 
formation of Ama and restoration of normal health is 
achieved with the help administration of Samshamana 
Basti by the virtue of their Madhura, Tikta Rasa with 
Snigdha, Laghu and Rookshaguna’s These three packaged 
Basti have mainly acts by virtue of their presence of drug 
effect as well as the procedure effect. 
Discussion on effect of the therapy 
 The administration of Utkleshana, Doshahara and 
Samshamana Basti showed the following results. 
 The effect of treatment after follow up, in the 
parameter of Apaka Shoonataanga was 76.25%, in 
reducing the Shotha. Finally the treatment was found 
statistically highly significant (P<0.01) indicating that 
it is the best package of Basti to eliminate the Ama 
factors in the body by which the Shotha is relieved. 
 The effect of treatment after follow up, in the 
parameter of Bramanasheelatwa was 75%, indicating 
that the treatment is highly effective in alleviating the 
Srotavarodha and Khavaigunya by which the 
movement of Vata is unopposed and pacified. 
Statistically also the treatment was found highly 
significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Vrushika Damshavata Vedana was 
75.28%, it alleviated the Srotavarodha and helped in 
free movement of Vyanavata, hence no pain and 
swelling. Finally statistically also the treatment was 
found highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Bahusandhi Shoola was 78.28%,. 
Indicating the treatment was found statistically highly 
significant (P<0.01) in reducing the pain in multiple 
joints ( poly arthritis). 
 The effect of treatment after follow up, in the 
parameter of Bahusandhi Shotha was 74.52%, 
indicating the treatment is statistically highly 
significant (P<0.01). in reducing the inflammation in 
multiple joints because Amapachana and 
Vatashamana are effects of the treatment. 
 The effect of treatment after follow up, in the 
parameter of Sandhigraha was 75.78%, indicating the 
treatment is statistically highly significant (P<0.01), in 
reducing the abnormal condition of joint movements. 
 The effect of treatment after follow up, in the 
parameter of Jwara was 74.69%, indicating the 
treatment is statistically highly significant (P<0.01), in 
reducing the Sookshma Ama rasa by alleviating the 
Ama factors and Amapachana effect of the treatment. 
 The effect of treatment after follow up, in the 
parameter of Vivarnata was 74.69%, indicating the 
treatment is statistically highly significant (P<0.01), in 
reducing the local discoloration. 
 The effect of treatment after follow up, in the 
parameter of Bahumootrata was 80%, indicating that 
the treatment is statistically highly significant 
(P<0.01), in reducing the accumulation of Ama in 
circulation there by reduction in quantity and 
frequency of Urine.  
 The effect of treatment after follow up, in the 
parameter of Stambha was 77.14%, indicating the 
treatment is found statistically highly significant 
(P<0.01). In reducing the Stiffness of Gatra and Sandhi 
by removing Srotovarodha and Ama. 
 The effect of treatment after follow up, in the 
parameter of Jwara was 74.69%, in reducing the 
Sooksma Ama rasa and relieving the obstruction of the 
Srotas. Finally the treatment was found statistically 
highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Angamarda was 70.29%, in reducing the 
Vata Prakopa relieve the body pain. Finally the 
treatment was found statistically highly significant 
(P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Aruchi was 76.63%, in reducing the Ama 
rasa, Mandagni and improves the loss of appetite. 
Finally the treatment was found statistically highly 
significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Gourava was 77.22%, in reducing 
obstruction of the Srotas and relieves the heaviness of 
the body. Finally the treatment was found statistically 
highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Dourbalya was 73.83%, in reducing the 
Jataragni and Dhatwagni Mandhya, improves the Bala 
of the patient. Finally the treatment was found 
statistically highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Agnimandhya was 76.08%, in reducing 
the Madagni by elimination of Ama at Jataragni and 
Dhatwagni level. Finally the treatment was found 
statistically highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Vibhanda was 74.10%, in reducing the 
constipation by Vatanulomata of Vata. Finally the 
treatment was found statistically highly significant 
(P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Alasya was 73.78%. Indicating that the 
treatment is statistically highly significant (P<0.01). in 
reducing the Alasya by providing proper neutrino to 
the Dhatus in the way of Samsamana Basti. 
 The effect of treatment after follow up, in the 
parameter of Nidralpata was 75.51%, in reducing the 
irregularity of Sleep by elimination the Ama and by 
regulating the Vata. Finally the treatment was found 
statistically highly significant (P<0.01). 
 The effect of treatment after follow up, in the 
parameter of Hb% was increased in 85.89%, 
indicating the treatment is statistically highly 
significant (<0.01) in oxidizing the Sookshma Ama rasa 
and improving Raktadhatwagni, giving rise to 
Raktadhatuposhana properly. 
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 The effect of treatment after follow up, in the 
parameter of ESR was 54.28%, indicating that the 
treatment is found statistically highly significant 
(P<0.01). in reducing the Amatatwa in Rasa dhatu and 
reducing the Gurutwa of fibrinogen, globulin and 
Plasma proteins resulting in normal ESR. 
 The effect of treatment after follow up, in the 
parameter of RA was 74.69%, indicating the treatment 
is statistically highly significant (P<0.01) by reducing 
the positive antigen (Amatatwa) naturally results in 
reduction of antibody production, which expressed 
through the test for RA factor. 
 The effect of treatment after follow up, in the 
parameter of CRP was 91.96%, indicating the 
treatment is statistically highly significant (P<0.01) by 
Amapachana, there is reduction of antigen antibody 
reactions resulting in absence of inflammation thereby 
lesser production of C Reactive proteins.  
Discussion on retention of Basti 
 During this research trial work after assessing the 
time period of retention capacity in 30 Amavata 
patients showed that, maximum number of patients 
i.e. 46.67% (14) have 11 to 15 hrs Anuvasanabasti 
retention capacity, followed by minimal number of 
patients i.e. 43.33% (13) have 16 to 20 hrs Anuvasana 
Basti retention capacity and remaining 10% (3) have 
06 to 10 hrs Anuvasana Basti retention capacity.  
 The above data suggests that the Bruhat-
saindhavadhyataila having the nature of longer 
period of retention in the body due to its 
pharmacodynamics.  
 During this research trial work after assessing the 
time period of retention capacity in 30 Amavata 
patients showed that, maximum number of patients 
i.e. 60% (18) have 06 to 10 mins. Utkleshanabasti 
retention capacity, followed by remaining minimal 
number of patients i.e. 40% (12) have 11 to 15 mins. 
Utkleshanabasti retention capacity. The above data 
revealed that, as Utkleshanabasti having the property 
of Picchila, Snigdha, Sooksma etc Guna’s it has 
retained more time as compare to Doshaharabasti.  
 During this research trial work after assessing the 
time period of retention capacity in 30 Amavata 
patients showed that, maximum number of patients 
i.e. 83.33% (25) have 06 to 10 mins. Doshaharabasti 
retention capacity, followed by remaining minimal 
number of patients i.e. 16.667% (05) have 0 to 05 
mins. Doshaharabasti retention capacity. The above 
data envisage that due to Ushna, Teekshna, Sookshma 
property, it was come out suddenly after 
administration.  
 During this research trial work after assessing the 
time period of retention capacity of Samshamana 
Basti in 30 Amavata patients showed that, maximum 
number of patients i.e. 70% (21) have 15 to 20 mins. 
Samshamanabasti retention capacity, followed by 
remaining minimal number of patients i.e. 30% (09) 
have 11 to 15 mins. Samshamanabasti retention 
capacity. The above data suggests that due to 
Mandha, Guru, Anabhishyandhiguna it will stay long 
time as compared to Utkleshana and Doshahara. 
 The Overall effect of treatment after follow up, in all 
prescribed parameters was 73.33% (22) and 26.66% 
(08) which are rated as good and fair response 
respectively. Finally the overall mean grade result is 
80.28 (22) under good response and 71.96 (08) 
under fair response in relieving the disease Amavata. 
Indicates that the administration of package of 
Utkleshana, Doshahara and Samshamana Basti in 
sequence of Kalavasti by adding Brihat 
Saindhavaditaila as Anuvasana Basti in between has 
good impact and to be considered as a best treatment 
in controlling, relieving and curing Amavata 
condition. 
CONCLUSION 
 No doubt Basti is one of the supreme line of 
treatment among all Panchakarama’s, because of its 
multi-dimensional actions in a multi corners.  
 The spectrum of Amavata is broad one; under this 
many Rheumatological disorders are explained. 
 In Amavata only Kaphasthana’s are becomes more 
susceptible to affect rather than others. In that only 
Sleshakaslesmayukta Sandhi’s are affected.  
 Basti is one of the prime treatment choice in chronic 
Amavata condition but in acute also has best 
therapy only when the condition of Ama becomes 
Niraama. 
 Among all three Basti i.e. Utkleshana, Doshahara and 
Samshamana, Utkleshana has fine effect on 
Doshatkleshana due to presence of Erandabeeja, 
Pippali, Hapusha etc are most Utkleshaka drugs 
without irritating to the patient.  
 The Doshahara Basti has supreme eradicative 
method of already Utklishtadosha as comparing to 
other Teekshna Basti mentioned in classics. Even 
after giving 800ml to the patients of Madhymabala 
etc., it not at all creates the side effects, because of 
presence of Madhanaphala and Kutaja.  
 The Samshamana Basti has best choice immediately 
after Shodhana because as it digest the Linadosha’s 
as well as prevents the further formation of Ama 
also it has prevents the complications if aroused by 
Doshahara or any Teekshna Basti and restore the 
normal health in all the ways, due to active 
ingredient like Goksheera, Priyangu, Rasnjana, 
Madhuka etc. 
 All the Basti’s are set under a packaged form having 
action like preventive, curative and promotive of 
health in a step ladder manner. 
 This packaged form Basti if we used under the light 
of Kaala Basti has highly significant results as 
compared to Yoga Basti.  
 The overall assessment mean result was 76.12 in 
both subjective and objective parameters of 
Amavata. 
 The retention capacity of Samshana Basti (6 – 10 
min, 70%) is relatively more compared to 
Utkleshana Basti (6 -10 min 60%).  
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 The retention capacity of Doshahara Basti was 6 - 10 
mins. 83.33%. 
 Retention time of Utkleshana Basti, Doshahara Basti 
and Samshamana Basti gradually increased and on 
the 8th day it was maximum up to 11 - 15 mins, 6 to 
10 mins. and 15 to 20 mins. respectively.  
 The retention capacity of Anuvasana Basti was 11 to 
15 hrs, 46.67%. 
 Retention capacity of Anuvasana Basti gradually 
increased on 7th day it was maximum up to 20 hours.  
 The Overall effect of treatment after follow up, in all 
prescribed parameters was 73.33% (22) and 
26.66% (08) which are rated as good and fair 
response respectively. Finally the overall mean 
grade result is 80.28 (22) under good response and 
71.96 (08) under fair response in relieving the 
disease Amavata. Indicates that the administration 
of package of Utkleshana, Doshahara and 
Samshamana Basti in sequence of Kala Bastiby 
adding Brihat Saindhavaditaila as Anuvasana Basti 
in between has good impact and to be considered as 
a best treatment in controlling, relieving and curing 
Amavata condition. 
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